Prasol Chemicals Limited (PRASOLCHEM)

Loading page…

Prasol Chemicals Limited (PRASOLCHEM) · mywealthgrid

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2024	Mar 2025
	877	1,012
COGS	648	724
Gross profit	229	288
	168	200
Operating profit (EBITDA)	61	88
OPM %	6.9%	8.7%
Depreciation	21	23
Interest	11	8
	11	3
Profit before tax	34	59
Tax	15	15
Tax %	45.8%	25.6%
	18	44
PAT margin %	2.1%	4.3%
EPS (₹)	—	—

₹ Cr	Mar 2024	Mar 2025
Equity capital	12	12
Reserves	314	356
	82	101
	218	255
Total equity & liabilities	626	723
	326	326
CWIP	22	21
Investments	0	0
	278	376
Total assets	626	723

Compounded sales growth

7 years: —
5 years: —
3 years: —
1 year: 16%

Compounded profit growth

7 years: —
5 years: —
3 years: —
1 year: 140%

Return on equity

7 years: —
5 years: —
3 years: —
Last year: 12%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2024	Mar 2025
Margins
Gross margin %	26.1%	28.5%
EBITDA margin %	6.9%	8.7%
EBIT margin %	4.5%	6.4%
PAT margin %	2.1%	4.3%
Working capital
Receivable days	67	71
Inventory days	56	76
Payable days	—	—
NWC days	—	—
Leverage
Current ratio	1.19	1.34
Debt to EBITDA	1.36	1.15
Debt to equity	0.25	0.27
Interest coverage	4.6	8.2
Asset turnover	1.4	1.4
Return ratios
Return on assets %	2.9%	6%
Return on capital employed %	12.7%	16.1%
Return on equity %	5.6%	11.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Jun 2026
	75.25%
	0.18%
	6.69%
Government	0%
	17.88%
No. of shareholders	1,19,467

Promoter holding up 0 percentage points since Jun 2026.

Loading shareholding…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

13 announcementsExport CSV

30 Sept 2026, 12:18 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

29 Sept 2026, 6:35 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Analyst / Investor Meet PDF

28 Sept 2026, 11:15 pmCompany Update

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Analyst / Investor Meet PDF

28 Sept 2026, 9:27 pmResult

Submission Of Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026

Financial Results PDF

28 Sept 2026, 9:05 pmBoard Meeting

Board Meeting Outcome for Submission Of Outcome Of The Board Meeting Held On September 28, 2026 Pursuant To Regulation 30 Of SEBI LODR, 2015

Outcome of Board Meeting PDF

28 Sept 2026, 8:17 pmInsider Trading / SAST

Closure of Trading Window

Closure of Trading Window PDF

22 Sept 2026, 7:01 pmBoard Meeting

Board Meeting Intimation for To Consider And Approve, Inter-Alia, The Un-Audited Financial Results Along With Limited Review Report For The Quarter Ended June 30, 2026.

Exchange filing PDF

16 Sept 2026, 6:36 pmCompany Update

Intimation Under Regulation 30(5)

General PDF

Date	Category	Subject	Filing
30 Sept 2026, 12:18 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
29 Sept 2026, 6:35 pm	Company Update Analyst / Investor Meet	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Loading announcements…

Prasol Chemicals Limited

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

Not in the F&O segment

No fund holdings on record

No events on record

Announcements

Offer and rights documents

Investor Presentation and earnings call

Compounded sales growth

Compounded profit growth

Return on equity

Prasol Chemicals Limited

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Ratios

Ratio timeline

Shareholding

Quarterly record

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Events

No events on record

Announcements

Ratio timeline

Quarterly record

Not in the F&O segment

No fund holdings on record

No events on record

Announcements

Offer and rights documents

Investor Presentation and earnings call

Profit & loss

Balance sheet

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity